Olfactory Odour Stimulation for Metabolism Control
NCT04223284 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2023-12-06
Summary
In this preliminary short-term study it is investigated, whether a short olfactory stimulation with D-Limonene leads to an acute improvement of glucose metabolism in patients with obesity.
Conditions
Interventions
- OTHER
-
D-Limonene
Patient will put the aspUraclip®, a commercially available mini-inhalator filled for our study purpose filled with 1% D-Limonene in the nose for 15 minutes
- OTHER
-
SLVO
Patient will put the aspUraclip®, a commercially available mini-inhalator filled for our study purpose filled with 1% SLVO in the nose for 15 minutes
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Katharina Timper, Dr. med · Endocrinology, Diabetology and Metabolism, University Hospital Basel
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-10
- Primary Completion
- 2022-05-10
- Completion
- 2022-10-13
Countries
- Switzerland
Study Locations
More Related Trials
-
The Effects of Modafinil to Counteract the Adverse Metabolic Consequences of Sleep Restriction
NCT00895570 ·Status: COMPLETED ·Phase: NA
-
Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals
NCT05971524 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome
NCT04912934 ·Status: COMPLETED
-
Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects
NCT01103726 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of LDX on Cognitive Processes and Appetite
NCT04181957 ·Status: TERMINATED ·Phase: NA
-
Brain Dopamine Function in Human Obesity
NCT03648892 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
NCT02796144 ·Status: TERMINATED ·Phase: PHASE4
-
The Role of Apathy in Glycemic Control
NCT00844090 ·Status: COMPLETED ·Phase: NA
-
Diabetes in Neuropsychiatric Disorders
NCT00446992 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
NCT01071044 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
NCT07045935 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity
NCT00339014 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Hesperetin in Combination With Sucrose on Energy Metabolism
NCT05705596 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
NCT00744224 ·Status: COMPLETED ·Phase: NA
-
The Effect of Obesity in Dexmedetomidine Metabolic Clearance
NCT02557867 ·Status: UNKNOWN ·Phase: PHASE4
-
Brain, Obesity, Dopamine and You Study
NCT01094756 ·Status: COMPLETED ·Phase: NA
-
Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease
NCT03817840 ·Status: COMPLETED
-
Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
NCT01160991 ·Status: COMPLETED ·Phase: NA
-
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
NCT04892199 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Changes in Metabolic Rate and Perceptual Indicators After Acute Ingestion of Paraxanthine
NCT05811923 ·Status: COMPLETED ·Phase: NA
-
Circadian Clocks and Eating Patterns (Cohort)
NCT04642534 ·Status: COMPLETED
-
Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM
NCT05405244 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Herbal Products on Metabolism and Hunger
NCT00198952 ·Status: COMPLETED ·Phase: NA
-
Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
NCT05492305 ·Status: UNKNOWN
-
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
NCT01281228 ·Status: COMPLETED ·Phase: NA